期刊文献+

Medtronic导管建立动脉损伤模型及对内膜增生的观察 被引量:5

Observation of Intimal Thickening in Rat Models of Carotid Artery Injury Established with Medtronic Balloon
下载PDF
导出
摘要 目的:采用Medtronic球囊建立大鼠颈动脉球囊损伤模型并观察损伤血管内膜的增生情况。方法:取35只雄性SD大鼠行左颈总动脉球囊内膜剥脱术建立动脉球囊损伤模型,分别于术后即刻、3、7、14、21、28和56d各取5只大鼠颈动脉损伤段和对侧正常动脉行病理切片及HE染色,观察内膜增生,图像分析软件分析内膜中膜的面积比值(I/M)。结果:球囊损伤使大鼠颈总动脉内膜剥脱和新生内膜增生,管腔狭窄。损伤后7d内膜开始增生,内膜面积0.129±0.010mm(2P<0.01),14~28d增生最明显(P<0.01),28~56d增生程度无明显差异(P>0.05);损伤后I/M比值逐渐增大,28d时I/M比值是7d时的6.5倍(P<0.01),为14d的1.7倍(P<0.01),56d与28d比较I/M比值无统计学差异(P>0.05)。结论:采用Medtronic球囊建立大鼠颈动脉球囊损伤模型简便、有效,可动态观察血管成形术后再狭窄的变化。 Objective: To observe the changes of intimal thickness in rat models of carotid artery injury established with medtronic balloon. Methods: Thirty-five male SD rats received balloon endarterectomy of the left carotid arteries. Immediately or at 3, 7, 14, 21, 28 and 56 d after injury, every five rats were sacrificed and harvested for the left injured carotid artery and right normal artery which were used in HE-stained pathological study of the intimal thickness. The pathological pictures were analyzed using special software in terms of intima to media area ratio (I/M). Results : Irregular intimal thickening and stenosis of artery cavity were observed since 7 d after balloon endarterectomy with the intima area 0.129±0.010 mm^2(p〈0.01), became pronounced between 14-28 d (P〈0.01) and seemed to remain stable between 28-56 d (P〉0.05). Post-injury I/M ratio increased over time to 6.5-fold of day 7 and 1.7-fold of day 14 after 28 days (P〈0.01) but remained stable thereafter through day 56 (P〉0.05). Conclusion: The rat carotid artery injury model established with Medtronic balloon procedure proved to be easy and effective for continuous study of restenosis after artery injury.
出处 《广州医学院学报》 2008年第3期17-20,共4页 Academic Journal of Guangzhou Medical College
基金 广东省卫生厅基金资助项目(A2005617)
关键词 颈动脉狭窄 疾病模型 动物 血管损伤 血管内膜 carotid stenosis disease model, animal artery injury artery intima
  • 相关文献

参考文献5

  • 1Schwartz RS. Pathophysiology of restenosis:interaction of thrombosis, hyperplasia, and/or remo deling [J]. Am J Cardiol, 1998,81(7A): 14E- 17E.
  • 2Levince GD. Restenosis following coronary angioplasty: clinical presentations and therapeutic options [J]. Clin Cardiol, 1995,18 (12):693 -703.
  • 3Collet JP, Montalescot G, Lison L, et al. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris [J]. Circulation, 2001,103(5):658-663.
  • 4Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST- elevation myocardial infarction [J]. N Engl J Med, 2006, 354(14):1477-1488.
  • 5SYNERGY Executive Committee. The SYNERGY trial: study design and rationale [J]. Am Heart J, 2002, 143(6): 952-960.

同被引文献37

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部